Ophthalmology companies

Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade.

Mirae Asset believes in changing the future through investment.

We are a venture studio leveraging Alloy’s pre-competitive drug discovery platforms. Established drug discovery, scientific, and lab resources allow entrepreneu…

Enabling tech startup companies to become market-shapers.